Media information

ScienceDirect drug discovery titles in the subscribed area include:

  • Actualités Pharmaceutiques
  • Actualités Pharmaceutiques Hospitalières
  • Annales Pharmaceutiques Françaises
  • Bioorganic & Medicinal Chemistry
  • Bioorganic & Medicinal Chemistry Letters
  • Bioorganic Chemistry
  • Biosystems
  • Combinatorial Chemistry - an Online Journal
  • Drug Discovery Today
  • Drug Discovery Today: BIOSILICO
  • Drug Discovery Today: Disease Mechanisms
  • Drug Discovery Today: Disease Models
  • Drug Discovery Today: TARGETS
  • Drug Discovery Today: Technologies
  • Drug Discovery Today: Therapeutic Strategies
  • European Journal of Medicinal Chemistry
  • European Journal of Pharmaceutical Sciences
  • International Journal of Neuropharmacology
  • Journal of Molecular Graphics and Modelling
  • Journal of the American Society for Mass
  • Spectrometry
  • Medical Hypotheses
  • Nanomedicine: Nanotechnology, Biology and Medicine
  • Neuropharmacology
  • Nuclear Medicine and Biology
  • Phytochemistry
  • Phytomedicine
  • Research in Social and Administrative Pharmacy
  • Tetrahedron
  • Tetrahedron Letters
  • Tetrahedron: Asymmetry
  • Update on Cancer Therapeutics
Discovery Package – New for 2012!

Discovery Package

Extend your reach across our targeted demographic with a unique package designed to promote your product or brand.

  • Banner advertising targeting up to 100,000 impressions per month across your choice of ScienceDirect drug discovery journal titles
  • Leaderboard advertisement in Drug Discovery Today Editor’s Choice Newsletter
  • Full page 4 colour advertisement in Drug Discovery Today
Package price $7,500 / €5,250 / £4,650

Ensure your message reaches your target audience of drug discovery professionals with our discovery package, tailored to your advertising needs. This package includes a range of integrated advertising solutions structured to reach a wider audience and offers considerable savings on published individual rates.

Contact your local sales representative to discuss package options